Organoids, three-dimensional stem cell-derived cultures that mimic human organ architecture and function, are revolutionizing biomedical research.
This article explores the transformative role of embryonic stem cell (ESC)-derived organoids in biomedical research and pharmaceutical development.
Induced pluripotent stem cell (iPSC)-derived organoids are revolutionizing biomedical research by providing physiologically relevant, human-specific models for studying disease mechanisms and accelerating drug development.
This article provides a comprehensive overview of adult stem cell (ASC)-derived organoids, detailing their foundational biology, methodological establishment, and transformative applications in biomedical research.
This article provides a comprehensive comparison between three-dimensional organoids and traditional two-dimensional cell cultures for researchers and drug development professionals.
This article provides a comprehensive framework for researchers, scientists, and drug development professionals to navigate the critical choice between zero-shot and fine-tuning approaches for single-cell Foundation Models (scFMs).
Single-cell foundation models (scFMs) have emerged as transformative tools for analyzing cellular heterogeneity, yet their ability to generalize across diverse tissue types and realistic clinical scenarios remains a critical, unanswered...
Single-cell foundation models (scFMs) promise to predict transcriptomic responses to genetic perturbations, offering a powerful in silico tool for drug target discovery and functional genomics.
The advent of single-cell foundation models (scFMs) represents a paradigm shift in the analysis of single-cell genomics data.
The clinical translation of single-chain variable fragments (scFvs) represents a promising yet challenging frontier in therapeutic development.